Inno-Gene SA
WSE:IGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Inno-Gene SA
WSE:IGN
|
PL |
|
GoldMoney Inc
TSX:XAU
|
CA |
|
P
|
Per Aarsleff Holding A/S
CSE:PAAL B
|
DK |
|
Tsumura & Co
TSE:4540
|
JP |
|
W
|
WW Holding Inc
TWSE:8442
|
KY |
|
Madhav Marbles and Granites Ltd
NSE:MADHAV
|
IN |
|
X
|
Xilinmen Furniture Co Ltd
SSE:603008
|
CN |
|
IIFL Securities Ltd
NSE:IIFLSEC
|
IN |
|
Nyfosa AB
STO:NYF
|
SE |
|
Redwood Trust Inc
NYSE:RWT
|
US |
|
Premium Brands Holdings Corp
TSX:PBH
|
CA |
Inno-Gene SA
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
